Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Gross Margin

Arena Pharmaceutical Gross Margin Chart (ARNA)

Arena Pharmaceutical annual/quarterly Gross Margin from 2000 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Arena Pharmaceutical Gross Margin for the quarter ending September 09, 2018 was $100m a 315.67% increase of 316m year over year
  • Arena Pharmaceutical Gross Margin for the last 12 months ending September 09, 2018 was $-296m a 21.49% decrease of -64m year over year
  • Arena Pharmaceutical Annual Gross Margin for 2017 was $-233m a 113.23% decrease of -263m from 2016
  • Arena Pharmaceutical Annual Gross Margin for 2016 was $31m a 724.84% increase of 223m from 2015
  • Arena Pharmaceutical Annual Gross Margin for 2014 was $-192m a 105.58% decrease of -203m from 2013
Other Margins & Efficiency Metrics:
  • Arena Pharmaceutical EBITDA Margin for the quarter ending December 12, 2017 was $-82m a -245.61% increase of 200m year over year
  • Arena Pharmaceutical Return on Capital % for the quarter ending September 09, 2018 was -14.88 a 16.87% decrease of -2.51 year over year
  • Arena Pharmaceutical Return on Equity % for the quarter ending September 09, 2018 was -25.18 a -6.61% increase of 1.66 year over year
View Chart On Koyfin

Quarterly ARNA Gross Margin Data

09/2018$100m
12/2017$-35m
09/2017$-155m
06/2017$-216m
03/2017$-186m
09/2016$-5m
06/2016$-122m
03/2016$-125m
12/2015$-202m
09/2015$-177m

Annual ARNA Gross Margin Data

2017$-233m
2016$31m
2014$-192m
2013$11m
2012$-109m
2006$-185m
2005$-192m
2004$100m
2003$-296m
2002$-129m